Niagen Bioscience management participates in Longevity Investors Conference panel - NAGE News | RalliesNiagen Bioscience management participates in Longevity Investors Conference panel
N
NAGE• Conference participation and investor meetings
- Niagen Bioscience will attend the Longevity Investors Conference in Gstaad, Switzerland, Sept. 14-17, 2026.
- CEO Rob Fried is scheduled for a consumer health investment panel on Sept. 16, 2026, 14:50-15:30 CEST.
- CFO Ozan Pamir will hold in-person one-on-one investor meetings during the conference.
•
